Viewing Study NCT05568459


Ignite Creation Date: 2025-12-24 @ 2:29 PM
Ignite Modification Date: 2025-12-29 @ 10:34 PM
Study NCT ID: NCT05568459
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-19
First Post: 2022-09-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial That Evaluates Disease Characteristics in Hemophilia B Adult Male Participants Receiving Prophylaxis With Standard of Care Factor IX Protein (FIX) Replacement Therapy
Sponsor: Regeneron Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module